33 C
New York
Thursday, June 11, 2026

Tag: brain

Arden’s Garden unveils premium functional beverage, FOCUS+™

The southeast's leader in premium cold-pressed juices and smoothies brings flavor and function in the trending mushroom beverage category. ATLANTA, Aug. 8, 2025 /PRNewswire/ -- Arden's...

Nuvalent Highlights Pipeline and Business Achievements, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2025 Financial Results

Initiated rolling NDA submission for zidesamtinib for TKI pre-treated patients with advanced ROS1-positive NSCLC, with target completion in the third quarter of 2025 Initiated ALKAZAR...

Sticker Mule partners with xAI to deploy Grok to 370 employees and millions of customers

AMSTERDAM, N.Y., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sticker Mule will bring Grok to 370 employees and millions of customers worldwide. Implementation begins in August with Grok being deployed across all departments including engineering, marketing, finance, support and manufacturing.

Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma

Modeyso is the first treatment option for this ultra-rare and aggressive brain tumor, which primarily affects children and young adults Accelerated approval based on an...

ONWARD Medical gibt Ernennung von Lucas Buchanan als Vorstandsmitglied bekannt

EINDHOVEN, Niederlande, Aug. 06, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD und US OTCQX: ONWRY), das führende Neurotechnologieunternehmen, das Pionierarbeit bei Therapien zur Wiederherstellung der Bewegungsfähigkeit, Funktion und Unabhängigkeit von Menschen mit Rückenmarksverletzungen (Spinal cord injury, SCI) und anderen Bewegungseinschränkungen leistet, gibt heute die Ernennung von Lucas Buchanan als nicht geschäftsführendes Mitglied seines Vorstands bekannt.

DeepSleep Bliss: 2025 Report Investigates the Brain-Sleep Connection Behind Brain Fog, Memory Lapses, and Sleep Difficulties

See how DeepSleep Bliss is redefining sleep support in 2025 by targeting BDNF—the brain’s “deep sleep molecule.” Learn about its chocolate-based formula, ingredient-first approach, and why it's gaining traction among wellness seekers battling brain fog, insomnia, and fatigue.
See how DeepSleep Bliss is redefining sleep support in 2025 by targeting BDNF—the brain’s “deep sleep molecule.” Learn about its chocolate-based formula, ingredient-first approach, and why it's gaining traction among wellness seekers battling brain fog, insomnia, and fatigue.

Brain Injury Association of America to Honor Centre for Neuro Skills’ Dr. Mark Ashley as Luminary of the Year

Brain Injury Association of America honors Centre for Neuro Skills' Dr. Mark Ashley as 2025 Luminary of the Year for contributions in brain injury field

ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors

EINDHOVEN, The Netherlands, Aug. 06, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announces the appointment of Lucas Buchanan as a non-executive member of its Board of Directors.

New revolutionary brain tech platform ‘ScreenIT’ puts smarter concussion care in reach

SYDNEY, Aug. 6, 2025 /PRNewswire/ -- A revolutionary new brain health assessment platform, ScreenIT, has officially launched, marking a major step forward in how...

Praxis Precision Medicines to Participate in Upcoming Fireside Chat

BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that CEO Marcio Souza will be participating a virtual fireside chat hosted by Piper Sandler senior research analyst Yasmin Rahini on August 7, 2025 at 11:00amEST.

Class is in Session: 7-Eleven, Inc. Aces Breakfast with Can’t-Miss Deals

Limited-time breakfast deals are serving up big flavors and bold savings before the first bell rings IRVING, Texas, Aug. 5, 2025 /PRNewswire/ -- Pencils are...

Hemispherian Receives FDA IND Clearance for First-in-Class Glioblastoma Therapeutic, GLIX1

OSLO, Norway, Aug. 5, 2025 /PRNewswire/ -- Hemispherian AS, a pioneering biotech company developing next-generation therapeutics for aggressive cancers, today announced that the U.S....

Sciaticyl’s “Nerve Reset” Discovery Sparks 2025 Surge in Sciatica Support Solutions Across U.S.

A powerful surge in online searches for natural sciatica remedies has thrust Sciaticyl into the spotlight, thanks to a peculiar “nerve reset” approach linked to ancient herbal wisdom and modern neuroscience. This unique formulation blends 11 ingredients—including Bacopa Monnieri, Alpha Lipoic Acid, and key nerve-regenerating compounds—positioning Sciaticyl as a leading curiosity point for those seeking non-surgical options. As nerve pain awareness grows in 2025, researchers and consumers alike are exploring how nutritional support may play a role in long-term sciatica recovery, vitality, and freedom from discomfort.
A powerful surge in online searches for natural sciatica remedies has thrust Sciaticyl into the spotlight, thanks to a peculiar “nerve reset” approach linked to ancient herbal wisdom and modern neuroscience. This unique formulation blends 11 ingredients—including Bacopa Monnieri, Alpha Lipoic Acid, and key nerve-regenerating compounds—positioning Sciaticyl as a leading curiosity point for those seeking non-surgical options. As nerve pain awareness grows in 2025, researchers and consumers alike are exploring how nutritional support may play a role in long-term sciatica recovery, vitality, and freedom from discomfort.

- A word from our sponsors -

spot_img
HomeTagsBrain